USD 20.88 billion
Male Breast Cancer Treatment Market Size, Share, Growth Analysis, By Product Type(Chemotherapy, Medication, and Others), By Application(Hospitals, Clinics and Others), By Treatment(Local Treatment, Radiation Therapy, Systemic Treatment and Targeted Therapy), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35D2234 |
Region:
Global |
Published Date: April, 2024
Pages:
219
|Tables:
89
|Figures:
71
Male Breast Cancer Treatment Market Insights
Global Male Breast Cancer Treatment Market size was valued at USD 20.88 billion in 2023, USD 23.05 billion in 2024 and is projected to grow USD 46.07 billion by 2031, growing at a CAGR of 10.4% in the forecast period (2024-2031).
Male breast cancer is an extremely uncommon kind of cancer that develops in a man's breast tissue. It happens when a breast cell divides quickly, resulting in a tumor. Due to the inheritance of aberrant (mutated) genes, particularly the BRCA2 gene, it may run in the family. Though it can happen at any age, it is more common among older men. The ageing population and rising rates of obesity are only two of the many variables that are predicted to propel the market's expansion. As an illustration, the Bristol-Myers Squibb Company and Clovis Oncology announced in July 2017 a wide clinical collaboration for the purpose of assessing the combination of the cancer medications Nivolumab and Rucaparib in Phase 2 and Phase 3 clinical trials across a variety of tumor types.
The American Cancer Society (ACS) estimates that 1 in 833 males will have breast cancer in their lifetime. Less than 1% of all cancers are caused by it. The survival rate has grown because of greater knowledge of male breast cancer, which has led to early cancer diagnosis and prompt, efficient treatment. The factors driving the expansion of the worldwide market for male breast cancer treatments are the rise in cancer cases, the advancement of biotechnology, and the development of novel medicines. But the absence of a comprehensive approach and the expensive price of research and development are impeding this market's expansion.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Chemotherapy
Fastest Growth
Medication
Growth Rate
10.4% CAGR
Global Male Breast Cancer Treatment Market ($ Bn)
Country Share by North America (%)
To get more reports on the above market click here to Buy The Report
Male Breast Cancer Treatment Market Segmental Analysis
The global male breast cancer treatment market is segmented based on treatment, product type, application and regional type. In terms of treatment, the market is grouped into local treatment, radiation therapy, systemic treatment and targeted therapy. Based on product type, the market is trifurcated into chemotherapy, medication and others. In terms of application, the market is segmented into hospitals, clinics and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Central & South America and Middle East & Africa. Some of the main factors propelling the growth of this product type include increasingly sophisticated technology and an increase in the demand for male breast cancer medicines.
Analysis by Product Type
As per categorization by product type, the market is classified into chemotherapy, medication and others. Among these, chemotherapy earned the largest share and continues to dominate the market. As of early 2024, there has been a great deal of innovation and adaptation in the worldwide market for male breast cancer treatment about the use of chemotherapy protocols that are especially suited to the distinct pathophysiology of male breast cancer. Patient outcomes have been enhanced and adverse effects have been decreased by the incorporation of precision medicine techniques and enhanced targeting of tumor-specific indicators. The implementation of adjuvant and neoadjuvant chemotherapy, in conjunction with developments in drug delivery methods, signifies a deliberate transition towards customized and efficacious treatment approaches, highlighting a dedication to managing this uncommon yet significant illness.
Medication and others form of product are poised for the fastest growth, driven by breakthroughs in targeted therapy and immunotherapy. These advances offer tailored treatment options that better address the genetic and molecular profiles of male breast cancer, leading to improved efficacy and patient outcomes. Furthermore, the development of oral chemotherapeutics and the increasing accessibility of personalized medicine are key factors contributing to this segment's expansion. As awareness and understanding of male breast cancer increase, so does the demand for these innovative, less invasive treatment options, making it a critical growth frontier.
Analysis by Application
Hospitals are at the forefront of implementing cutting-edge targeted medicines and personalized medicine strategies into their treatment protocols. Genomic testing is increasingly being used to inform treatment choices, enabling more focused and efficient approaches. Additionally, hospitals are using multidisciplinary teams more frequently to provide patients with all-encompassing care that includes systemic therapies, radiation therapy, and surgery customized to each patient's unique cancer profile. In the fight against male breast cancer, this all-encompassing strategy improves patient quality of life and treatment outcomes.
Due to their flexibility in embracing and putting into practice the most recent advancements in treatment and personalized care models, clinics and other cancer institutions are anticipated to grow at the quickest rate. More specialized treatments, such as genetic counselling and access to clinical trials—both essential for expanding treatment options—are frequently provided in these locations. In comparison to hospitals, their usual smaller size enables a more individualized and patient-centered approach, greatly improving patient results and satisfaction. Furthermore, the increasing inclination towards outpatient care models facilitates the swift growth of this industry, rendering these establishments indispensable to the developing field of male breast cancer therapy.
Global Male Breast Cancer Treatment Market By Product Type (%)
To get detailed analysis on other segments, Request For Free Sample Report
Male Breast Cancer Treatment Market Regional Insights
There are several reasons for North America's commercial dominance in male breast cancer treatments. This leadership is mostly due to the region's large elderly population, who are more prone to cancer, as well as state-of-the-art developments in biotechnology and medical sciences. Furthermore, a surge in diagnoses has resulted from lifestyle variables, such as younger demographics' increased alcohol intake, which has increased the need for novel therapies. Europe, which comes in second, is helped along by strong government backing, which includes large expenditures on research and development (R&D) in the healthcare industry. The development of novel treatments and therapies is aided by these investments. Furthermore, widespread access to these advancements is guaranteed by Europe's high health spending commitment, which makes full care and support for male breast cancer patients easier to obtain.
The fastest-growing region is now Asia Pacific, primarily due to expanding healthcare spending, bettering healthcare infrastructure, and raising awareness. Even though it is expanding, Latin America confronts difficulties due to disparities in healthcare funding and access, but it also shows promise thanks to slow but steady advancements in cancer care systems. With its varied healthcare environments, the Middle East and Africa area is expanding because of multinational partnerships and focused government programmes aimed at improving oncology care. Asia Pacific is a major growth engine in the global market due to its substantial patient population and quick adoption of innovative treatments.
Global Male Breast Cancer Treatment Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Male Breast Cancer Treatment Market Dynamics
Drivers
Increasing Awareness and Early Detection
- The increased awareness and early detection of the disease are two of the main factors propelling the global market for male breast cancer treatments. Campaigns for awareness and educational initiatives have made a substantial contribution to the early detection of male breast cancer, which is essential for better survival rates and successful treatment. Better patient outcomes result from early detection through screening programmes and the use of cutting-edge diagnostic technology, which allow healthcare practitioners to start treatment earlier.
Rapid Progress in Therapeutic Approaches
- The introduction of innovative treatment modalities and the quick advancement of medical research have greatly advanced the industry. Personalised medicine, immunotherapy, and targeted therapy advancements have completely changed the way male breast cancer is treated, providing less harmful and more efficient alternatives. The market acceptance of these innovative therapies is fuelled by developments that not only increase the effectiveness of treatments but also improve patients' quality of life both during and after treatment.
Restraints
Restricted Clinical Trials and Research
- As male breast cancer is less common than its female counterpart, there are fewer clinical trials and less research dedicated to treating male patients. The lack of gender-specific research makes it difficult to design treatment protocols that are optimal, and it could lead to men receiving care based on data that is mostly obtained from studies conducted on women, which could have an impact on treatment efficacy.
Regulatory and Reimbursement Challenges
- The process of getting new cancer treatments approved through the regulatory system can be difficult and time-consuming. Furthermore, patients may not be able to receive the most recent treatments if their insurance does not fully cover costly yet new therapy. To promote the expansion of the global market for male breast cancer treatments and to make advanced medicines more accessible, it is imperative that these challenges be addressed.
Request Free Customization of this report to help us to meet your business objectives.
Male Breast Cancer Treatment Market Competitive Landscape
This creates a dynamic competitive market where businesses are constantly researching and innovating to create therapies that are less harmful and more effective. Prominent global participants comprise Pfizer Inc., Johnson & Johnson, Novartis AG, AstraZeneca, and Merck & Co., Inc. These businesses are leading the way in the introduction of innovative treatments and making significant investments in R&D to broaden their product lines. Mergers, acquisitions, and collaborations are often used tactics to improve market presence and cater to the changing demands of patients globally.
Top Player’s Company Profiles
- BioNumerik Pharmaceuticals Inc. (US)
- Bristol-Myers Squibb Company (US)
- AstraZeneca (UK)
- Pfizer (US)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Bayer AG (Germany)
- Sanofi (France)
- Achieve Life Sciences Inc. (US)
- Eli Lilly and Company (US)
- F. Hoffmann-La Roche (Switzerland)
- Novartis AG (Switzerland)
- Seattle Genetics Inc. (US)
- GlaxoSmithKline plc. (UK)
- Sun Pharmaceutical Industries Ltd. (India)
- Accord Healthcare (UK)
Recent Developments
- In July 2022, Promising results from an advanced trial of an antibody-drug combination intended to target and kill cancer cells in male breast cancer were revealed by Seattle Genetics Inc. For patients with advanced stages of the disease, the treatment demonstrated a considerable improvement in survival rates without progression, providing new hope. This discovery offers a formidable new tool in the battle against male breast cancer and signifies a substantial advancement in the use of targeted medicines.
- In February 2023, Results of a ground-breaking trial conducted by AstraZeneca on the usage of its PARP inhibitor, particularly in male breast cancer patients with BRCA mutations, were made public. The medication is now positioned as a possible first-line treatment for this subgroup after the research showed remarkable efficacy in reducing the progression of the disease. This breakthrough highlights AstraZeneca's trailblazing work in extending precision medicine's application to men's breast cancer treatment paradigms—a field that had received little attention before.
- In August 2023, Pfizer declared that a Phase 3 trial for a new targeted treatment for male breast cancer with genetic alterations has been successfully completed. This discovery represents a major advancement and gives hope for more individualized and efficient treatment choices. The treatment focuses on BRCA gene abnormalities, which are associated with an increased risk of breast cancer in men. This demonstrates Pfizer's dedication to meeting unmet needs in this patient population.
Male Breast Cancer Treatment Key Market Trends
- Oncology Landscape is Changing: There have been notable shifts in the market patterns for male breast cancer, which can be attributed to increased awareness and attention given to this underappreciated area of oncology. Research and development in the male breast cancer market has been prompted by the recognition that men can also be affected by breast cancer, even though the disease has historically been mostly linked to women. One trend that stands out is the rise in the number of male instances of breast cancer, which has forced the medical community to commit funds for specialized research and cutting-edge care.
- Advancements in Early Detection of Male Breast Cancer: The rise in advocacy and awareness initiatives for male breast cancer is another significant development in the market. The public and medical community are being educated on the characteristics and incidence of male breast cancer, and these efforts are gaining traction. Given that male breast cancer is frequently detected at a later stage than that of female breast cancer, this increased awareness is essential for early identification and prompt action. As a result, the industry is seeing a boom in diagnostic instruments and technologies that are meant to increase the rate of early detection and enable timely medical intervention.
Male Breast Cancer Treatment Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the worldwide market for male breast cancer treatment is being driven towards less toxic and more effective treatment alternatives, which will greatly improve patient outcomes. This is due to increased awareness, early identification, and rapid advancements in therapeutic techniques. The lack of emphasis on research and clinical trials specifically targeted at men, together with obstacles related to regulation and reimbursement, hinders the progress of the worldwide market by making it more difficult to develop and make effective treatments for male breast cancer accessible.
The market for male breast cancer treatments is highly competitive, with top players like Pfizer Inc., Johnson & Johnson, and Novartis AG collaborating strategically to develop safer, more effective treatments and increase their global market share. The field of oncology is changing because of expanding funding and recognition for research on male breast cancer, as well as an increase in cases and increased awareness of the significance of early diagnosis and sophisticated diagnostic technologies.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 20.88 billion |
| Market size value in 2031 | USD 46.07 billion |
| Growth Rate | 10.4% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Male Breast Cancer Treatment Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Male Breast Cancer Treatment Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Male Breast Cancer Treatment Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Male Breast Cancer Treatment Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Male Breast Cancer Treatment Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Male Breast Cancer Treatment Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
